Micardis Plus 80/12

Micardis Plus 80/12 is a medicine authorised by Swissmedic under authorisation number 55970. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 August 2002 and the authorisation is valid without a time limit. ATC code C09DA07 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 55970
  • ATC C09DA07
  • Synthetic medicines
Authorisation data
Authorisation number55970
NameMicardis Plus 80/12
Full nameMicardis Plus 80/12,5 mg, Tabletten
Authorisation holderBoehringer Ingelheim (Schweiz) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA07
First authorisation30 August 2002
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Micardis Plus 80/12,5 mg, TablettenB30 August 2002
3Micardis Plus 80/25 mg, TablettenB06 March 2008

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
528Tablette(n)C09DA0702.07.2.B
798Tablette(n)C09DA0702.07.2.B
928Tablette(n)C09DA0702.07.2.B
1198Tablette(n)C09DA0702.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Micardis Plus 80/12 authorised in Switzerland?

Yes. Micardis Plus 80/12 is authorised by Swissmedic under authorisation number 55970, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Micardis Plus 80/12 have?

Micardis Plus 80/12 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Micardis Plus 80/12?

The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com